The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …

Sarcoidosis is a multi-system inflammatory disorder of unknown etiology resulting in
formation of non-caseating granulomas. Cardiac involvement—which is associated with …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

Developing consensus recommendations for rare diseases requires adapting the
methodology for preparing traditional guidelines for clinical practice. The most obvious …

Background—This study was designed to assess the epidemiology, characteristics, and
outcome of cardiac sarcoidosis (CS) in Finland. Methods and Results—We identified in …

Sarcoidosis is a systemic disease of unknown etiology defined by the presence of
noncaseating granulomatous inflammation that can cause organ damage and diminished …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Background There are no published clinical consensus guidelines or systematic evaluation
supporting the use of corticosteroids for the treatment of cardiac sarcoidosis. The purpose of …

Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …